Scope Pharmachem

Loading Scope Pharmachem Plus...

Mupirocin EP Impurity E Sodium salt (CAS 116182-44-6) | ChemLume Reference Standards

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Mupirocin EP Impurity E Sodium salt

CAT No:	CL-M055021
CAS No:	116182-44-6
Mol. F:	C₂₆H₄₄O₉ : Na
Mol. Wt.:	500.6
Rel. Cas No:	71087-96-2 (free base)
Chemical Name:	9-[[(2E)-4-[(2R,3RS,4aS,7S,8S,8aR)-3,8-dihydroxy-2-[(1S,2S)-2-hydroxy-1-methylpropyl]hexahydro2H,5H-pyrano[4,3-b]pyran-7-yl]-3-methylbut-2-enoyl]oxy]nonanoic acid Sodium salt (as per EP); 9-{(E)-4-[(2R,3RS,4aS,7S,8S,8aR)-3,8-Dihydroxy-2-{(2S,3S)-3-hydroxybutan-2-yl}octahydropyrano[3,2-c]pyran-7-yl]-3-methylbut-2-enoyloxy}nonanoic acid Sodium salt (as per USP)
Purity:	>99.0%
SMILES:	O=C(O)CCCCCCCCOC(/C=C(C)/C[C@H]1[C@H](O)[C@@]2([H])[C@@](CO1)([H])CC(O)[C@@H]([C@@H](C)[C@@H](O)C)O2)=O.[Na]
Inventory Status:	In Stock
Storage Conditions:	Store at 2°C - 8°C

COA MSDS

Enquire on WhatsApp

Origin: India • Standard Dossier Available

This impurity is related to Mupirocin EP Impurity E Sodium salt and is provided with comprehensive characterization data in accordance with international regulatory guidelines.

Suitable for analytical method development (AMD), analytical method validation (AMV), Quality Control (QC) release testing, Abbreviated New Drug Applications (ANDA), DMF filing, and commercial production batch release.

Standard Analytical Dossier Included: